InsiderTrades

Form 4 for CMMB Chemomab Therapeutics Ltd.

Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-24 · accession 0001178913-22-002173 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-05-25 2022-05-24 CMMB Maryles Joel Michael Dir P - Purchase $2.88 +433 1,433 +43% +$1,247
DM 2022-05-25 2021-04-19+ CMMB Maryles Joel Michael Dir A - Grant $0.00 +18.7K 11.9K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common American Depositary Shares 2022-05-24 P A 400 $2.89 1,400 D — — (F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. (F2) Includes the previously reported 1,000 ADSs of the Company, as reported by Mr. Joel Maryles on Form 4 filed with the SEC on March 21, 2022.
2 Common American Depositary Shares 2022-05-24 P A 33 $2.76 1,433 D — — (F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. (F2) Includes the previously reported 1,000 ADSs of the Company, as reported by Mr. Joel Maryles on Form 4 filed with the SEC on March 21, 2022.
3 Derivative Option to Purchase American Depositary Shares 2022-03-07 A A 6,820 $0.00 6,820 D $3.53 · — to 2032-03-07 6,820 American Depositary Shares (F3) No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. (F4) These options vest and become exercisable in their entirety on March 16, 2023.
4 Derivative Option to Purchase American Depositary Shares 2021-04-19 A A 11,884 $0.00 11,884 D $27.26 · — to 2031-04-19 11,884 American Depositary Shares (F3) No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. (F5) These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.